Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THYRODOUL2: Intermediate Cervical Block in Thyroid Surgery
NCT04585126Unknown
- Sponsor
- CHU Caen Normandie
- Start
- Nov 2019
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in Graves' disease and multinodular goiter (MNG) (2 arms), sponsored by CHU Caen Normandie. Primary endpoint: Effect on recurrent laryngeal nerve monitoring. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
Graves' diseasemultinodular goiter (MNG)
Beyond the preview
Go deeper on NCT04585126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585126.